BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8656960)

  • 1. Prevalence and assessment of qualitative olfactory dysfunction in different age groups.
    Nordin S; Murphy C; Davidson TM; Quiñonez C; Jalowayski AA; Ellison DW
    Laryngoscope; 1996 Jun; 106(6):739-44. PubMed ID: 8656960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on the prognostic significance of qualitative olfactory dysfunction.
    Reden J; Maroldt H; Fritz A; Zahnert T; Hummel T
    Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):139-44. PubMed ID: 17006637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation and symptoms of chemosensory impairment: one thousand consecutive cases from the Nasal Dysfunction Clinic in San Diego.
    Harris R; Davidson TM; Murphy C; Gilbert PE; Chen M
    Am J Rhinol; 2006; 20(1):101-8. PubMed ID: 16539304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training.
    Liu DT; Sabha M; Damm M; Philpott C; Oleszkiewicz A; Hähner A; Hummel T
    Laryngoscope; 2021 Mar; 131(3):618-623. PubMed ID: 33210732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlates of parosmia and phantosmia among smell disorders.
    Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain lesion-pattern analysis in patients with olfactory dysfunctions following head trauma.
    Lötsch J; Ultsch A; Eckhardt M; Huart C; Rombaux P; Hummel T
    Neuroimage Clin; 2016; 11():99-105. PubMed ID: 26937377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative smell/taste disorders as sequelae of acute COVID-19.
    Ercoli T; Masala C; Pinna I; Orofino G; Solla P; Rocchi L; Defazio G
    Neurol Sci; 2021 Dec; 42(12):4921-4926. PubMed ID: 34557966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on difference in olfactory response in dysosmia patients].
    Shibuya E; Asahina N; Suzuki E; Suzaki H
    Nihon Jibiinkoka Gakkai Kaiho; 2002 Jul; 105(7):783-9. PubMed ID: 12174611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euosmia: a rare form of parosmia.
    Landis BN; Frasnelli J; Hummel T
    Acta Otolaryngol; 2006 Jan; 126(1):101-3. PubMed ID: 16308262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the clinical usefulness of structured questions in parosmia assessment.
    Landis BN; Frasnelli J; Croy I; Hummel T
    Laryngoscope; 2010 Aug; 120(8):1707-13. PubMed ID: 20641087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensory decrease in different forms of olfactory dysfunction.
    Migneault-Bouchard C; Hsieh JW; Hugentobler M; Frasnelli J; Landis BN
    J Neurol; 2020 Jan; 267(1):138-143. PubMed ID: 31586261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of postviral qualitative olfactory dysfunction using the short SSParoT in patients with and without parosmia.
    Sekine R; Menzel S; Hähner A; Mori E; Hummel T
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):469-472. PubMed ID: 36006515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of odor hedonic perception: the Sniffin' sticks parosmia test (SSParoT).
    Liu DT; Welge-Lüssen A; Besser G; Mueller CA; Renner B
    Sci Rep; 2020 Oct; 10(1):18019. PubMed ID: 33093474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parosmia and phantosmia: clinical update].
    Macario S; Hsieh JW; Daskalou D; Voruz F; Landis BN
    Rev Med Suisse; 2022 Oct; 18(798):1837-1842. PubMed ID: 36200960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthonasal and retronasal odor identification in patients with parosmia.
    Li S; Boscolo-Rizzo P; Uderzo F; Tirelli G; Whitcroft KL; Hummel T
    Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):4933-4938. PubMed ID: 37338584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normative data for the "Sniffin' Sticks" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects.
    Hummel T; Kobal G; Gudziol H; Mackay-Sim A
    Eur Arch Otorhinolaryngol; 2007 Mar; 264(3):237-43. PubMed ID: 17021776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation of qualitative olfactory dysfunction.
    Frasnelli J; Landis BN; Heilmann S; Hauswald B; Hüttenbrink KB; Lacroix JS; Leopold DA; Hummel T
    Eur Arch Otorhinolaryngol; 2004 Aug; 261(7):411-5. PubMed ID: 14610680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory Processing in Male Children with Autism: Atypical Odor Threshold and Identification.
    Muratori F; Tonacci A; Billeci L; Catalucci T; Igliozzi R; Calderoni S; Narzisi A
    J Autism Dev Disord; 2017 Oct; 47(10):3243-3251. PubMed ID: 28744761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of electrophysiological measures of olfactory function.
    Lötsch J; Hummel T
    Behav Brain Res; 2006 Jun; 170(1):78-83. PubMed ID: 16563529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Olfactory evoked potentials and contingent negative variation in expert assessment of disordered sense of smell].
    Matern G; Matthias C; Mrowinski D
    Laryngorhinootologie; 1995 Feb; 74(2):118-21. PubMed ID: 7710604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.